Jamaica to launch new female condom as part of HIV/AIDS prevention efforts

NewsGuard 100/100 Score

Jamaica's National Family Planning Board in the next few weeks plans to launch a new female condom in an effort to provide women with increased control over HIV/AIDS prevention methods, the Jamaica Gleaner reports.

According to the Gleaner, the second-generation female condom has been improved to be more user friendly while still providing protection against HIV/AIDS, other sexually transmitted infections and unplanned pregnancies.

The new version is made from nitrile polymer, which is thin, odorless and stronger than the latex used to manufacture male condoms.

In addition to being stronger, the FC2 is less noisy, hypoallergenic and not tight or constricting, the Gleaner reports.

It also can be used with oil- and water-based lubricants, inserted up to eight hours before intercourse and stored for up to five years with no special storage conditions.

In the coming month, the family planning board will conduct a workshop on the female condom to increase its use and address some of the negative stigma surrounding the contraceptive (Jamaica Gleaner, 4/21).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study reveals increased risk of immune abnormalities in children of women with HIV